Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Hip Cohort Liposomal Bupivacaine	61
Overall Study	STARTED	Hip Cohort Ropivacaine	60
Overall Study	STARTED	Knee Cohort Liposomal Bupivacaine	59
Overall Study	STARTED	Knee Cohort Ropivacaine	59
Overall Study	COMPLETED	Hip Cohort Liposomal Bupivacaine	60
Overall Study	COMPLETED	Hip Cohort Ropivacaine	58
Overall Study	COMPLETED	Knee Cohort Liposomal Bupivacaine	59
Overall Study	COMPLETED	Knee Cohort Ropivacaine	59
Overall Study	NOT COMPLETED	Hip Cohort Liposomal Bupivacaine	1
Overall Study	NOT COMPLETED	Hip Cohort Ropivacaine	2
Overall Study	NOT COMPLETED	Knee Cohort Liposomal Bupivacaine	0
Overall Study	NOT COMPLETED	Knee Cohort Ropivacaine	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02543801/flow